Concourse Financial Group Securities, Inc. Mirum Pharmaceuticals, Inc. Put Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
173Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$257 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$198 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$173 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$143 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$128 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.46B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...